nodes	percent_of_prediction	percent_of_DWPC	metapath
Amprenavir—ABCC1—breast cancer	0.206	0.559	CbGaD
Amprenavir—CYP2D6—breast cancer	0.0632	0.172	CbGaD
Amprenavir—CYP3A4—breast cancer	0.0542	0.147	CbGaD
Amprenavir—ABCB1—breast cancer	0.0451	0.123	CbGaD
Amprenavir—ABCC1—Idarubicin—breast cancer	0.0405	0.0867	CbGbCtD
Amprenavir—CYP2B6—Thiotepa—breast cancer	0.0191	0.0408	CbGbCtD
Amprenavir—ABCC1—Mitoxantrone—breast cancer	0.0174	0.0373	CbGbCtD
Amprenavir—ABCC1—Epirubicin—breast cancer	0.0141	0.0302	CbGbCtD
Amprenavir—ABCC1—Paclitaxel—breast cancer	0.0139	0.0298	CbGbCtD
Amprenavir—ABCC1—Irinotecan—breast cancer	0.0137	0.0294	CbGbCtD
Amprenavir—CYP2C9—Anastrozole—breast cancer	0.0133	0.0285	CbGbCtD
Amprenavir—CYP3A5—Lapatinib—breast cancer	0.0132	0.0283	CbGbCtD
Amprenavir—CYP2B6—Raloxifene—breast cancer	0.0127	0.0272	CbGbCtD
Amprenavir—CYP2C8—Lapatinib—breast cancer	0.0127	0.0272	CbGbCtD
Amprenavir—ABCC1—Vinblastine—breast cancer	0.0122	0.0261	CbGbCtD
Amprenavir—ABCB1—Toremifene—breast cancer	0.0118	0.0253	CbGbCtD
Amprenavir—CYP2C19—Lapatinib—breast cancer	0.0107	0.0228	CbGbCtD
Amprenavir—CYP3A4—Exemestane—breast cancer	0.0102	0.0218	CbGbCtD
Amprenavir—CYP2C9—Idarubicin—breast cancer	0.0101	0.0216	CbGbCtD
Amprenavir—ABCC1—Docetaxel—breast cancer	0.0101	0.0215	CbGbCtD
Amprenavir—CYP2C8—Raloxifene—breast cancer	0.00964	0.0206	CbGbCtD
Amprenavir—CYP2D6—Idarubicin—breast cancer	0.00921	0.0197	CbGbCtD
Amprenavir—CYP3A4—Letrozole—breast cancer	0.00867	0.0186	CbGbCtD
Amprenavir—ABCB1—Lapatinib—breast cancer	0.00861	0.0184	CbGbCtD
Amprenavir—CYP2B6—Tamoxifen—breast cancer	0.00841	0.018	CbGbCtD
Amprenavir—CYP3A4—Anastrozole—breast cancer	0.00773	0.0165	CbGbCtD
Amprenavir—ABCC1—Doxorubicin—breast cancer	0.00749	0.016	CbGbCtD
Amprenavir—ABCC1—Methotrexate—breast cancer	0.00726	0.0155	CbGbCtD
Amprenavir—CYP3A4—Toremifene—breast cancer	0.00707	0.0151	CbGbCtD
Amprenavir—CYP3A5—Tamoxifen—breast cancer	0.00662	0.0142	CbGbCtD
Amprenavir—CYP3A4—Fulvestrant—breast cancer	0.00657	0.0141	CbGbCtD
Amprenavir—CYP2B6—Irinotecan—breast cancer	0.00646	0.0138	CbGbCtD
Amprenavir—CYP2C8—Tamoxifen—breast cancer	0.00637	0.0136	CbGbCtD
Amprenavir—CYP3A4—Thiotepa—breast cancer	0.00586	0.0125	CbGbCtD
Amprenavir—CYP2C9—Capecitabine—breast cancer	0.00552	0.0118	CbGbCtD
Amprenavir—CYP3A4—Ixabepilone—breast cancer	0.00536	0.0115	CbGbCtD
Amprenavir—CYP2C19—Tamoxifen—breast cancer	0.00534	0.0114	CbGbCtD
Amprenavir—CYP3A4—Lapatinib—breast cancer	0.00516	0.011	CbGbCtD
Amprenavir—CYP3A5—Paclitaxel—breast cancer	0.00516	0.011	CbGbCtD
Amprenavir—CYP3A5—Irinotecan—breast cancer	0.00509	0.0109	CbGbCtD
Amprenavir—CYP2C8—Paclitaxel—breast cancer	0.00496	0.0106	CbGbCtD
Amprenavir—ABCB1—Vinorelbine—breast cancer	0.00478	0.0102	CbGbCtD
Amprenavir—CYP2C8—Fluorouracil—breast cancer	0.00469	0.01	CbGbCtD
Amprenavir—CYP2D6—Vinorelbine—breast cancer	0.0045	0.00963	CbGbCtD
Amprenavir—CYP2C9—Tamoxifen—breast cancer	0.00444	0.00951	CbGbCtD
Amprenavir—ABCB1—Tamoxifen—breast cancer	0.00431	0.00923	CbGbCtD
Amprenavir—ABCB1—Mitoxantrone—breast cancer	0.0042	0.009	CbGbCtD
Amprenavir—CYP2D6—Tamoxifen—breast cancer	0.00406	0.00869	CbGbCtD
Amprenavir—CYP3A4—Raloxifene—breast cancer	0.00391	0.00837	CbGbCtD
Amprenavir—CYP3A5—Docetaxel—breast cancer	0.00373	0.00798	CbGbCtD
Amprenavir—ABCB1—Gemcitabine—breast cancer	0.00371	0.00795	CbGbCtD
Amprenavir—CYP2B6—Doxorubicin—breast cancer	0.00353	0.00755	CbGbCtD
Amprenavir—CYP2C9—Paclitaxel—breast cancer	0.00346	0.0074	CbGbCtD
Amprenavir—ABCB1—Paclitaxel—breast cancer	0.00336	0.00718	CbGbCtD
Amprenavir—ABCB1—Irinotecan—breast cancer	0.00331	0.00709	CbGbCtD
Amprenavir—CYP2C9—Fluorouracil—breast cancer	0.00327	0.00701	CbGbCtD
Amprenavir—ABCB1—Vinblastine—breast cancer	0.00294	0.0063	CbGbCtD
Amprenavir—CYP3A4—Vinorelbine—breast cancer	0.00286	0.00612	CbGbCtD
Amprenavir—CYP2D6—Vinblastine—breast cancer	0.00277	0.00594	CbGbCtD
Amprenavir—CYP3A4—Tamoxifen—breast cancer	0.00258	0.00553	CbGbCtD
Amprenavir—CYP3A4—Mitoxantrone—breast cancer	0.00252	0.00539	CbGbCtD
Amprenavir—ABCB1—Docetaxel—breast cancer	0.00243	0.00519	CbGbCtD
Amprenavir—CYP3A4—Paclitaxel—breast cancer	0.00201	0.0043	CbGbCtD
Amprenavir—CYP3A4—Irinotecan—breast cancer	0.00198	0.00425	CbGbCtD
Amprenavir—ABCB1—Doxorubicin—breast cancer	0.00181	0.00387	CbGbCtD
Amprenavir—CYP3A4—Vinblastine—breast cancer	0.00176	0.00377	CbGbCtD
Amprenavir—ABCB1—Methotrexate—breast cancer	0.00175	0.00375	CbGbCtD
Amprenavir—CYP2D6—Doxorubicin—breast cancer	0.0017	0.00365	CbGbCtD
Amprenavir—CYP3A4—Docetaxel—breast cancer	0.00145	0.00311	CbGbCtD
Amprenavir—CYP3A4—Doxorubicin—breast cancer	0.00108	0.00232	CbGbCtD
Amprenavir—Fosamprenavir—CYP3A4—breast cancer	0.00093	0.5	CrCbGaD
Amprenavir—Darunavir—CYP3A4—breast cancer	0.00093	0.5	CrCbGaD
Amprenavir—Musculoskeletal discomfort—Mitoxantrone—breast cancer	7.76e-05	0.00072	CcSEcCtD
Amprenavir—Cardiac disorder—Docetaxel—breast cancer	7.69e-05	0.000713	CcSEcCtD
Amprenavir—Vomiting—Tamoxifen—breast cancer	7.68e-05	0.000712	CcSEcCtD
Amprenavir—Paraesthesia—Mitoxantrone—breast cancer	7.65e-05	0.000709	CcSEcCtD
Amprenavir—Paraesthesia—Irinotecan—breast cancer	7.65e-05	0.000709	CcSEcCtD
Amprenavir—Rash—Tamoxifen—breast cancer	7.61e-05	0.000706	CcSEcCtD
Amprenavir—Dermatitis—Tamoxifen—breast cancer	7.61e-05	0.000705	CcSEcCtD
Amprenavir—Erythema multiforme—Capecitabine—breast cancer	7.59e-05	0.000703	CcSEcCtD
Amprenavir—Headache—Tamoxifen—breast cancer	7.57e-05	0.000701	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Gemcitabine—breast cancer	7.56e-05	0.000701	CcSEcCtD
Amprenavir—Vomiting—Melphalan—breast cancer	7.52e-05	0.000697	CcSEcCtD
Amprenavir—Liver function test abnormal—Epirubicin—breast cancer	7.46e-05	0.000692	CcSEcCtD
Amprenavir—Rash—Melphalan—breast cancer	7.46e-05	0.000691	CcSEcCtD
Amprenavir—Paraesthesia—Gemcitabine—breast cancer	7.45e-05	0.000691	CcSEcCtD
Amprenavir—Cardiac disorder—Capecitabine—breast cancer	7.45e-05	0.00069	CcSEcCtD
Amprenavir—Dermatitis—Melphalan—breast cancer	7.45e-05	0.00069	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Fluorouracil—breast cancer	7.43e-05	0.000689	CcSEcCtD
Amprenavir—Asthenia—Vinorelbine—breast cancer	7.41e-05	0.000687	CcSEcCtD
Amprenavir—Decreased appetite—Irinotecan—breast cancer	7.41e-05	0.000687	CcSEcCtD
Amprenavir—Decreased appetite—Mitoxantrone—breast cancer	7.41e-05	0.000687	CcSEcCtD
Amprenavir—Nausea—Vinblastine—breast cancer	7.38e-05	0.000684	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Irinotecan—breast cancer	7.36e-05	0.000682	CcSEcCtD
Amprenavir—Fatigue—Irinotecan—breast cancer	7.35e-05	0.000681	CcSEcCtD
Amprenavir—Fatigue—Mitoxantrone—breast cancer	7.35e-05	0.000681	CcSEcCtD
Amprenavir—Vomiting—Goserelin—breast cancer	7.33e-05	0.00068	CcSEcCtD
Amprenavir—Paraesthesia—Fluorouracil—breast cancer	7.33e-05	0.000679	CcSEcCtD
Amprenavir—Pruritus—Vinorelbine—breast cancer	7.31e-05	0.000677	CcSEcCtD
Amprenavir—Aspartate aminotransferase increased—Epirubicin—breast cancer	7.28e-05	0.000675	CcSEcCtD
Amprenavir—Rash—Goserelin—breast cancer	7.27e-05	0.000674	CcSEcCtD
Amprenavir—Dermatitis—Goserelin—breast cancer	7.27e-05	0.000674	CcSEcCtD
Amprenavir—Mental disorder—Docetaxel—breast cancer	7.26e-05	0.000673	CcSEcCtD
Amprenavir—Myalgia—Paclitaxel—breast cancer	7.25e-05	0.000672	CcSEcCtD
Amprenavir—Headache—Goserelin—breast cancer	7.23e-05	0.00067	CcSEcCtD
Amprenavir—Malnutrition—Docetaxel—breast cancer	7.22e-05	0.000669	CcSEcCtD
Amprenavir—Decreased appetite—Gemcitabine—breast cancer	7.21e-05	0.000669	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—breast cancer	7.2e-05	0.000667	CcSEcCtD
Amprenavir—Nausea—Tamoxifen—breast cancer	7.17e-05	0.000665	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Gemcitabine—breast cancer	7.17e-05	0.000664	CcSEcCtD
Amprenavir—Discomfort—Paclitaxel—breast cancer	7.16e-05	0.000664	CcSEcCtD
Amprenavir—Abdominal discomfort—Methotrexate—breast cancer	7.16e-05	0.000663	CcSEcCtD
Amprenavir—Fatigue—Gemcitabine—breast cancer	7.16e-05	0.000663	CcSEcCtD
Amprenavir—Alanine aminotransferase increased—Epirubicin—breast cancer	7.13e-05	0.000661	CcSEcCtD
Amprenavir—Decreased appetite—Fluorouracil—breast cancer	7.09e-05	0.000658	CcSEcCtD
Amprenavir—Asthenia—Thiotepa—breast cancer	7.08e-05	0.000656	CcSEcCtD
Amprenavir—Diarrhoea—Vinorelbine—breast cancer	7.07e-05	0.000655	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Fluorouracil—breast cancer	7.05e-05	0.000653	CcSEcCtD
Amprenavir—Mental disorder—Capecitabine—breast cancer	7.03e-05	0.000652	CcSEcCtD
Amprenavir—Nausea—Melphalan—breast cancer	7.02e-05	0.000651	CcSEcCtD
Amprenavir—Malnutrition—Capecitabine—breast cancer	6.99e-05	0.000648	CcSEcCtD
Amprenavir—Neutropenia—Methotrexate—breast cancer	6.98e-05	0.000647	CcSEcCtD
Amprenavir—Pruritus—Thiotepa—breast cancer	6.98e-05	0.000647	CcSEcCtD
Amprenavir—Gastrointestinal pain—Mitoxantrone—breast cancer	6.97e-05	0.000646	CcSEcCtD
Amprenavir—Gastrointestinal pain—Irinotecan—breast cancer	6.97e-05	0.000646	CcSEcCtD
Amprenavir—Liver function test abnormal—Doxorubicin—breast cancer	6.9e-05	0.00064	CcSEcCtD
Amprenavir—Flatulence—Capecitabine—breast cancer	6.89e-05	0.000638	CcSEcCtD
Amprenavir—Nausea—Goserelin—breast cancer	6.85e-05	0.000635	CcSEcCtD
Amprenavir—Nervous system disorder—Paclitaxel—breast cancer	6.81e-05	0.000632	CcSEcCtD
Amprenavir—Diarrhoea—Thiotepa—breast cancer	6.75e-05	0.000626	CcSEcCtD
Amprenavir—Skin disorder—Paclitaxel—breast cancer	6.75e-05	0.000626	CcSEcCtD
Amprenavir—Abdominal pain—Irinotecan—breast cancer	6.74e-05	0.000624	CcSEcCtD
Amprenavir—Abdominal pain—Mitoxantrone—breast cancer	6.74e-05	0.000624	CcSEcCtD
Amprenavir—Aspartate aminotransferase increased—Doxorubicin—breast cancer	6.73e-05	0.000624	CcSEcCtD
Amprenavir—Depression—Methotrexate—breast cancer	6.64e-05	0.000615	CcSEcCtD
Amprenavir—Anorexia—Paclitaxel—breast cancer	6.62e-05	0.000614	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Methotrexate—breast cancer	6.6e-05	0.000612	CcSEcCtD
Amprenavir—Alanine aminotransferase increased—Doxorubicin—breast cancer	6.6e-05	0.000611	CcSEcCtD
Amprenavir—Vomiting—Vinorelbine—breast cancer	6.57e-05	0.000609	CcSEcCtD
Amprenavir—Tremor—Capecitabine—breast cancer	6.55e-05	0.000607	CcSEcCtD
Amprenavir—Neutropenia—Epirubicin—breast cancer	6.53e-05	0.000606	CcSEcCtD
Amprenavir—Rash—Vinorelbine—breast cancer	6.51e-05	0.000604	CcSEcCtD
Amprenavir—Dermatitis—Vinorelbine—breast cancer	6.51e-05	0.000603	CcSEcCtD
Amprenavir—Headache—Vinorelbine—breast cancer	6.47e-05	0.0006	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Paclitaxel—breast cancer	6.33e-05	0.000587	CcSEcCtD
Amprenavir—Hyperglycaemia—Epirubicin—breast cancer	6.3e-05	0.000584	CcSEcCtD
Amprenavir—Hepatobiliary disease—Methotrexate—breast cancer	6.3e-05	0.000583	CcSEcCtD
Amprenavir—Vomiting—Thiotepa—breast cancer	6.27e-05	0.000581	CcSEcCtD
Amprenavir—Paraesthesia—Paclitaxel—breast cancer	6.24e-05	0.000578	CcSEcCtD
Amprenavir—Rash—Thiotepa—breast cancer	6.22e-05	0.000577	CcSEcCtD
Amprenavir—Dermatitis—Thiotepa—breast cancer	6.22e-05	0.000576	CcSEcCtD
Amprenavir—Headache—Thiotepa—breast cancer	6.18e-05	0.000573	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Epirubicin—breast cancer	6.18e-05	0.000572	CcSEcCtD
Amprenavir—Myalgia—Docetaxel—breast cancer	6.14e-05	0.000569	CcSEcCtD
Amprenavir—Nausea—Vinorelbine—breast cancer	6.14e-05	0.000569	CcSEcCtD
Amprenavir—Asthenia—Irinotecan—breast cancer	6.11e-05	0.000567	CcSEcCtD
Amprenavir—Asthenia—Mitoxantrone—breast cancer	6.11e-05	0.000567	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—breast cancer	6.1e-05	0.000566	CcSEcCtD
Amprenavir—Neutropenia—Doxorubicin—breast cancer	6.04e-05	0.00056	CcSEcCtD
Amprenavir—Decreased appetite—Paclitaxel—breast cancer	6.04e-05	0.00056	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Paclitaxel—breast cancer	6e-05	0.000556	CcSEcCtD
Amprenavir—Fatigue—Paclitaxel—breast cancer	5.99e-05	0.000555	CcSEcCtD
Amprenavir—Asthenia—Gemcitabine—breast cancer	5.95e-05	0.000552	CcSEcCtD
Amprenavir—Myalgia—Capecitabine—breast cancer	5.95e-05	0.000551	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—breast cancer	5.91e-05	0.000548	CcSEcCtD
Amprenavir—Hepatobiliary disease—Epirubicin—breast cancer	5.89e-05	0.000546	CcSEcCtD
Amprenavir—Discomfort—Capecitabine—breast cancer	5.88e-05	0.000545	CcSEcCtD
Amprenavir—Pruritus—Gemcitabine—breast cancer	5.87e-05	0.000544	CcSEcCtD
Amprenavir—Nausea—Thiotepa—breast cancer	5.86e-05	0.000543	CcSEcCtD
Amprenavir—Hyperglycaemia—Doxorubicin—breast cancer	5.83e-05	0.00054	CcSEcCtD
Amprenavir—Diarrhoea—Irinotecan—breast cancer	5.83e-05	0.00054	CcSEcCtD
Amprenavir—Diarrhoea—Mitoxantrone—breast cancer	5.83e-05	0.00054	CcSEcCtD
Amprenavir—Nervous system disorder—Docetaxel—breast cancer	5.78e-05	0.000535	CcSEcCtD
Amprenavir—Pruritus—Fluorouracil—breast cancer	5.77e-05	0.000535	CcSEcCtD
Amprenavir—Skin disorder—Docetaxel—breast cancer	5.72e-05	0.00053	CcSEcCtD
Amprenavir—Stevens-Johnson syndrome—Doxorubicin—breast cancer	5.71e-05	0.00053	CcSEcCtD
Amprenavir—Gastrointestinal pain—Paclitaxel—breast cancer	5.68e-05	0.000527	CcSEcCtD
Amprenavir—Diarrhoea—Gemcitabine—breast cancer	5.68e-05	0.000526	CcSEcCtD
Amprenavir—Erythema multiforme—Methotrexate—breast cancer	5.65e-05	0.000524	CcSEcCtD
Amprenavir—Anorexia—Docetaxel—breast cancer	5.61e-05	0.00052	CcSEcCtD
Amprenavir—Nervous system disorder—Capecitabine—breast cancer	5.59e-05	0.000518	CcSEcCtD
Amprenavir—Diarrhoea—Fluorouracil—breast cancer	5.58e-05	0.000518	CcSEcCtD
Amprenavir—Cardiac disorder—Methotrexate—breast cancer	5.55e-05	0.000514	CcSEcCtD
Amprenavir—Skin disorder—Capecitabine—breast cancer	5.54e-05	0.000513	CcSEcCtD
Amprenavir—Connective tissue disorder—Epirubicin—breast cancer	5.49e-05	0.000509	CcSEcCtD
Amprenavir—Abdominal pain—Paclitaxel—breast cancer	5.49e-05	0.000509	CcSEcCtD
Amprenavir—Hepatobiliary disease—Doxorubicin—breast cancer	5.45e-05	0.000505	CcSEcCtD
Amprenavir—Anorexia—Capecitabine—breast cancer	5.44e-05	0.000504	CcSEcCtD
Amprenavir—Vomiting—Irinotecan—breast cancer	5.42e-05	0.000502	CcSEcCtD
Amprenavir—Vomiting—Mitoxantrone—breast cancer	5.42e-05	0.000502	CcSEcCtD
Amprenavir—Rash—Mitoxantrone—breast cancer	5.37e-05	0.000498	CcSEcCtD
Amprenavir—Rash—Irinotecan—breast cancer	5.37e-05	0.000498	CcSEcCtD
Amprenavir—Dermatitis—Mitoxantrone—breast cancer	5.37e-05	0.000497	CcSEcCtD
Amprenavir—Dermatitis—Irinotecan—breast cancer	5.37e-05	0.000497	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Docetaxel—breast cancer	5.37e-05	0.000497	CcSEcCtD
Amprenavir—Headache—Irinotecan—breast cancer	5.34e-05	0.000495	CcSEcCtD
Amprenavir—Headache—Mitoxantrone—breast cancer	5.34e-05	0.000495	CcSEcCtD
Amprenavir—Paraesthesia—Docetaxel—breast cancer	5.29e-05	0.00049	CcSEcCtD
Amprenavir—Erythema multiforme—Epirubicin—breast cancer	5.29e-05	0.00049	CcSEcCtD
Amprenavir—Vomiting—Gemcitabine—breast cancer	5.28e-05	0.000489	CcSEcCtD
Amprenavir—Mental disorder—Methotrexate—breast cancer	5.23e-05	0.000485	CcSEcCtD
Amprenavir—Rash—Gemcitabine—breast cancer	5.23e-05	0.000485	CcSEcCtD
Amprenavir—Dermatitis—Gemcitabine—breast cancer	5.23e-05	0.000485	CcSEcCtD
Amprenavir—Malnutrition—Methotrexate—breast cancer	5.2e-05	0.000482	CcSEcCtD
Amprenavir—Headache—Gemcitabine—breast cancer	5.2e-05	0.000482	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Capecitabine—breast cancer	5.2e-05	0.000482	CcSEcCtD
Amprenavir—Cardiac disorder—Epirubicin—breast cancer	5.19e-05	0.000481	CcSEcCtD
Amprenavir—Vomiting—Fluorouracil—breast cancer	5.19e-05	0.000481	CcSEcCtD
Amprenavir—Rash—Fluorouracil—breast cancer	5.15e-05	0.000477	CcSEcCtD
Amprenavir—Dermatitis—Fluorouracil—breast cancer	5.14e-05	0.000476	CcSEcCtD
Amprenavir—Paraesthesia—Capecitabine—breast cancer	5.12e-05	0.000475	CcSEcCtD
Amprenavir—Decreased appetite—Docetaxel—breast cancer	5.12e-05	0.000475	CcSEcCtD
Amprenavir—Headache—Fluorouracil—breast cancer	5.11e-05	0.000474	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Docetaxel—breast cancer	5.08e-05	0.000471	CcSEcCtD
Amprenavir—Connective tissue disorder—Doxorubicin—breast cancer	5.08e-05	0.000471	CcSEcCtD
Amprenavir—Fatigue—Docetaxel—breast cancer	5.08e-05	0.000471	CcSEcCtD
Amprenavir—Nausea—Mitoxantrone—breast cancer	5.06e-05	0.000469	CcSEcCtD
Amprenavir—Nausea—Irinotecan—breast cancer	5.06e-05	0.000469	CcSEcCtD
Amprenavir—Asthenia—Paclitaxel—breast cancer	4.99e-05	0.000462	CcSEcCtD
Amprenavir—Decreased appetite—Capecitabine—breast cancer	4.96e-05	0.000459	CcSEcCtD
Amprenavir—Nausea—Gemcitabine—breast cancer	4.93e-05	0.000457	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Capecitabine—breast cancer	4.92e-05	0.000456	CcSEcCtD
Amprenavir—Fatigue—Capecitabine—breast cancer	4.92e-05	0.000456	CcSEcCtD
Amprenavir—Pruritus—Paclitaxel—breast cancer	4.92e-05	0.000456	CcSEcCtD
Amprenavir—Mental disorder—Epirubicin—breast cancer	4.9e-05	0.000454	CcSEcCtD
Amprenavir—Erythema multiforme—Doxorubicin—breast cancer	4.89e-05	0.000453	CcSEcCtD
Amprenavir—Malnutrition—Epirubicin—breast cancer	4.87e-05	0.000451	CcSEcCtD
Amprenavir—Nausea—Fluorouracil—breast cancer	4.85e-05	0.000449	CcSEcCtD
Amprenavir—Gastrointestinal pain—Docetaxel—breast cancer	4.82e-05	0.000446	CcSEcCtD
Amprenavir—Cardiac disorder—Doxorubicin—breast cancer	4.8e-05	0.000445	CcSEcCtD
Amprenavir—Flatulence—Epirubicin—breast cancer	4.8e-05	0.000445	CcSEcCtD
Amprenavir—Diarrhoea—Paclitaxel—breast cancer	4.75e-05	0.000441	CcSEcCtD
Amprenavir—Gastrointestinal pain—Capecitabine—breast cancer	4.66e-05	0.000432	CcSEcCtD
Amprenavir—Abdominal pain—Docetaxel—breast cancer	4.66e-05	0.000432	CcSEcCtD
Amprenavir—Mental disorder—Doxorubicin—breast cancer	4.53e-05	0.00042	CcSEcCtD
Amprenavir—Abdominal pain—Capecitabine—breast cancer	4.51e-05	0.000418	CcSEcCtD
Amprenavir—Malnutrition—Doxorubicin—breast cancer	4.5e-05	0.000417	CcSEcCtD
Amprenavir—Flatulence—Doxorubicin—breast cancer	4.44e-05	0.000411	CcSEcCtD
Amprenavir—Myalgia—Methotrexate—breast cancer	4.43e-05	0.00041	CcSEcCtD
Amprenavir—Vomiting—Paclitaxel—breast cancer	4.42e-05	0.00041	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	4.4e-05	0.000408	CcSEcCtD
Amprenavir—Rash—Paclitaxel—breast cancer	4.38e-05	0.000406	CcSEcCtD
Amprenavir—Dermatitis—Paclitaxel—breast cancer	4.38e-05	0.000406	CcSEcCtD
Amprenavir—Discomfort—Methotrexate—breast cancer	4.38e-05	0.000406	CcSEcCtD
Amprenavir—Headache—Paclitaxel—breast cancer	4.35e-05	0.000404	CcSEcCtD
Amprenavir—Asthenia—Docetaxel—breast cancer	4.23e-05	0.000392	CcSEcCtD
Amprenavir—Pruritus—Docetaxel—breast cancer	4.17e-05	0.000386	CcSEcCtD
Amprenavir—Nervous system disorder—Methotrexate—breast cancer	4.16e-05	0.000386	CcSEcCtD
Amprenavir—Myalgia—Epirubicin—breast cancer	4.14e-05	0.000384	CcSEcCtD
Amprenavir—Nausea—Paclitaxel—breast cancer	4.13e-05	0.000383	CcSEcCtD
Amprenavir—Skin disorder—Methotrexate—breast cancer	4.12e-05	0.000382	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	4.12e-05	0.000381	CcSEcCtD
Amprenavir—Discomfort—Epirubicin—breast cancer	4.09e-05	0.00038	CcSEcCtD
Amprenavir—Asthenia—Capecitabine—breast cancer	4.09e-05	0.000379	CcSEcCtD
Amprenavir—Anorexia—Methotrexate—breast cancer	4.05e-05	0.000375	CcSEcCtD
Amprenavir—Pruritus—Capecitabine—breast cancer	4.03e-05	0.000374	CcSEcCtD
Amprenavir—Diarrhoea—Docetaxel—breast cancer	4.03e-05	0.000374	CcSEcCtD
Amprenavir—Diarrhoea—Capecitabine—breast cancer	3.9e-05	0.000362	CcSEcCtD
Amprenavir—Nervous system disorder—Epirubicin—breast cancer	3.9e-05	0.000361	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Methotrexate—breast cancer	3.87e-05	0.000358	CcSEcCtD
Amprenavir—Skin disorder—Epirubicin—breast cancer	3.86e-05	0.000358	CcSEcCtD
Amprenavir—Myalgia—Doxorubicin—breast cancer	3.83e-05	0.000355	CcSEcCtD
Amprenavir—Paraesthesia—Methotrexate—breast cancer	3.81e-05	0.000353	CcSEcCtD
Amprenavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	3.81e-05	0.000353	CcSEcCtD
Amprenavir—Discomfort—Doxorubicin—breast cancer	3.79e-05	0.000351	CcSEcCtD
Amprenavir—Anorexia—Epirubicin—breast cancer	3.79e-05	0.000351	CcSEcCtD
Amprenavir—Vomiting—Docetaxel—breast cancer	3.74e-05	0.000347	CcSEcCtD
Amprenavir—Rash—Docetaxel—breast cancer	3.71e-05	0.000344	CcSEcCtD
Amprenavir—Dermatitis—Docetaxel—breast cancer	3.71e-05	0.000344	CcSEcCtD
Amprenavir—Decreased appetite—Methotrexate—breast cancer	3.69e-05	0.000342	CcSEcCtD
Amprenavir—Headache—Docetaxel—breast cancer	3.69e-05	0.000342	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Methotrexate—breast cancer	3.66e-05	0.00034	CcSEcCtD
Amprenavir—Fatigue—Methotrexate—breast cancer	3.66e-05	0.000339	CcSEcCtD
Amprenavir—Vomiting—Capecitabine—breast cancer	3.63e-05	0.000336	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Epirubicin—breast cancer	3.62e-05	0.000335	CcSEcCtD
Amprenavir—Nervous system disorder—Doxorubicin—breast cancer	3.6e-05	0.000334	CcSEcCtD
Amprenavir—Rash—Capecitabine—breast cancer	3.6e-05	0.000333	CcSEcCtD
Amprenavir—Dermatitis—Capecitabine—breast cancer	3.59e-05	0.000333	CcSEcCtD
Amprenavir—Headache—Capecitabine—breast cancer	3.57e-05	0.000331	CcSEcCtD
Amprenavir—Skin disorder—Doxorubicin—breast cancer	3.57e-05	0.000331	CcSEcCtD
Amprenavir—Paraesthesia—Epirubicin—breast cancer	3.57e-05	0.000331	CcSEcCtD
Amprenavir—Anorexia—Doxorubicin—breast cancer	3.5e-05	0.000325	CcSEcCtD
Amprenavir—Nausea—Docetaxel—breast cancer	3.5e-05	0.000324	CcSEcCtD
Amprenavir—Gastrointestinal pain—Methotrexate—breast cancer	3.47e-05	0.000322	CcSEcCtD
Amprenavir—Decreased appetite—Epirubicin—breast cancer	3.45e-05	0.00032	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Epirubicin—breast cancer	3.43e-05	0.000318	CcSEcCtD
Amprenavir—Fatigue—Epirubicin—breast cancer	3.43e-05	0.000317	CcSEcCtD
Amprenavir—Nausea—Capecitabine—breast cancer	3.39e-05	0.000314	CcSEcCtD
Amprenavir—Abdominal pain—Methotrexate—breast cancer	3.36e-05	0.000311	CcSEcCtD
Amprenavir—Musculoskeletal discomfort—Doxorubicin—breast cancer	3.35e-05	0.00031	CcSEcCtD
Amprenavir—Paraesthesia—Doxorubicin—breast cancer	3.3e-05	0.000306	CcSEcCtD
Amprenavir—Gastrointestinal pain—Epirubicin—breast cancer	3.25e-05	0.000301	CcSEcCtD
Amprenavir—Decreased appetite—Doxorubicin—breast cancer	3.2e-05	0.000296	CcSEcCtD
Amprenavir—Gastrointestinal disorder—Doxorubicin—breast cancer	3.17e-05	0.000294	CcSEcCtD
Amprenavir—Fatigue—Doxorubicin—breast cancer	3.17e-05	0.000294	CcSEcCtD
Amprenavir—Abdominal pain—Epirubicin—breast cancer	3.14e-05	0.000291	CcSEcCtD
Amprenavir—Asthenia—Methotrexate—breast cancer	3.05e-05	0.000282	CcSEcCtD
Amprenavir—Gastrointestinal pain—Doxorubicin—breast cancer	3.01e-05	0.000279	CcSEcCtD
Amprenavir—Pruritus—Methotrexate—breast cancer	3e-05	0.000278	CcSEcCtD
Amprenavir—Abdominal pain—Doxorubicin—breast cancer	2.91e-05	0.000269	CcSEcCtD
Amprenavir—Diarrhoea—Methotrexate—breast cancer	2.9e-05	0.000269	CcSEcCtD
Amprenavir—Asthenia—Epirubicin—breast cancer	2.85e-05	0.000264	CcSEcCtD
Amprenavir—Pruritus—Epirubicin—breast cancer	2.81e-05	0.000261	CcSEcCtD
Amprenavir—Diarrhoea—Epirubicin—breast cancer	2.72e-05	0.000252	CcSEcCtD
Amprenavir—Vomiting—Methotrexate—breast cancer	2.7e-05	0.00025	CcSEcCtD
Amprenavir—Rash—Methotrexate—breast cancer	2.68e-05	0.000248	CcSEcCtD
Amprenavir—Dermatitis—Methotrexate—breast cancer	2.67e-05	0.000248	CcSEcCtD
Amprenavir—Headache—Methotrexate—breast cancer	2.66e-05	0.000247	CcSEcCtD
Amprenavir—Asthenia—Doxorubicin—breast cancer	2.64e-05	0.000244	CcSEcCtD
Amprenavir—Pruritus—Doxorubicin—breast cancer	2.6e-05	0.000241	CcSEcCtD
Amprenavir—Vomiting—Epirubicin—breast cancer	2.53e-05	0.000234	CcSEcCtD
Amprenavir—Nausea—Methotrexate—breast cancer	2.52e-05	0.000234	CcSEcCtD
Amprenavir—Diarrhoea—Doxorubicin—breast cancer	2.52e-05	0.000233	CcSEcCtD
Amprenavir—Rash—Epirubicin—breast cancer	2.5e-05	0.000232	CcSEcCtD
Amprenavir—Dermatitis—Epirubicin—breast cancer	2.5e-05	0.000232	CcSEcCtD
Amprenavir—Headache—Epirubicin—breast cancer	2.49e-05	0.000231	CcSEcCtD
Amprenavir—Nausea—Epirubicin—breast cancer	2.36e-05	0.000219	CcSEcCtD
Amprenavir—Vomiting—Doxorubicin—breast cancer	2.34e-05	0.000217	CcSEcCtD
Amprenavir—Rash—Doxorubicin—breast cancer	2.32e-05	0.000215	CcSEcCtD
Amprenavir—Dermatitis—Doxorubicin—breast cancer	2.32e-05	0.000215	CcSEcCtD
Amprenavir—Headache—Doxorubicin—breast cancer	2.3e-05	0.000213	CcSEcCtD
Amprenavir—Nausea—Doxorubicin—breast cancer	2.18e-05	0.000202	CcSEcCtD
Amprenavir—CYP2C9—Metabolism—BCHE—breast cancer	3.25e-06	5.92e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—ERCC2—breast cancer	3.25e-06	5.91e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—SLC5A5—breast cancer	3.24e-06	5.9e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—CYP3A4—breast cancer	3.24e-06	5.9e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—GPX1—breast cancer	3.23e-06	5.89e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—breast cancer	3.23e-06	5.88e-05	CbGpPWpGaD
Amprenavir—ABCC1—Disease—CTNNB1—breast cancer	3.22e-06	5.87e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—SLC5A5—breast cancer	3.21e-06	5.85e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—GSTA1—breast cancer	3.21e-06	5.85e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—IDH1—breast cancer	3.21e-06	5.85e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—HSP90AA1—breast cancer	3.2e-06	5.83e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—CYP1A1—breast cancer	3.2e-06	5.83e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—COMT—breast cancer	3.2e-06	5.82e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—CYP1B1—breast cancer	3.18e-06	5.8e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—GSTP1—breast cancer	3.18e-06	5.79e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—NAT2—breast cancer	3.18e-06	5.78e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—ERCC2—breast cancer	3.17e-06	5.78e-05	CbGpPWpGaD
Amprenavir—ABCB1—Transmembrane transport of small molecules—RAF1—breast cancer	3.17e-06	5.77e-05	CbGpPWpGaD
Amprenavir—ABCC1—Disease—CDKN1A—breast cancer	3.15e-06	5.74e-05	CbGpPWpGaD
Amprenavir—ABCC1—Disease—PTEN—breast cancer	3.14e-06	5.72e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—HMOX1—breast cancer	3.14e-06	5.71e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—SLC2A1—breast cancer	3.13e-06	5.7e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—NQO1—breast cancer	3.13e-06	5.7e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—ITPR1—breast cancer	3.13e-06	5.7e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—HSP90AA1—breast cancer	3.12e-06	5.69e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—NCOA1—breast cancer	3.11e-06	5.67e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—SLC2A1—breast cancer	3.1e-06	5.65e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—NQO1—breast cancer	3.1e-06	5.65e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—STK11—breast cancer	3.07e-06	5.59e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—CYP19A1—breast cancer	3.07e-06	5.59e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—CYP3A4—breast cancer	3.05e-06	5.56e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—MTHFR—breast cancer	3.05e-06	5.56e-05	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—PIK3CB—breast cancer	3.04e-06	5.55e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	3.04e-06	5.53e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—NCOA1—breast cancer	3.04e-06	5.53e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—CYP3A4—breast cancer	3.03e-06	5.51e-05	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—PTGS2—breast cancer	3.02e-06	5.5e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	3.01e-06	5.48e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—ABCB1—breast cancer	3.01e-06	5.48e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—CYP1B1—breast cancer	3e-06	5.47e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—CYP19A1—breast cancer	2.99e-06	5.45e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—STK11—breast cancer	2.99e-06	5.45e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—MTHFR—breast cancer	2.98e-06	5.43e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—CYP1B1—breast cancer	2.98e-06	5.42e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—TYMS—breast cancer	2.96e-06	5.38e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—HSP90AA1—breast cancer	2.94e-06	5.36e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—NCOR1—breast cancer	2.92e-06	5.32e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PLA2G4A—breast cancer	2.92e-06	5.32e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—GSTM1—breast cancer	2.92e-06	5.32e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—HSP90AA1—breast cancer	2.92e-06	5.31e-05	CbGpPWpGaD
Amprenavir—ABCC1—Disease—SRC—breast cancer	2.91e-06	5.31e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.88e-06	5.25e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—NCOA1—breast cancer	2.86e-06	5.21e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—COMT—breast cancer	2.85e-06	5.19e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—GSTP1—breast cancer	2.84e-06	5.17e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—NCOA1—breast cancer	2.84e-06	5.17e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—STK11—breast cancer	2.82e-06	5.14e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—CYP19A1—breast cancer	2.82e-06	5.14e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—CAV1—breast cancer	2.81e-06	5.13e-05	CbGpPWpGaD
Amprenavir—ABCC1—Disease—STAT3—breast cancer	2.81e-06	5.12e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—HMOX1—breast cancer	2.8e-06	5.1e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—GPX1—breast cancer	2.8e-06	5.1e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—STK11—breast cancer	2.8e-06	5.09e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—CYP19A1—breast cancer	2.8e-06	5.09e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—ITPR1—breast cancer	2.79e-06	5.09e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—MED12—breast cancer	2.78e-06	5.07e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—DPYD—breast cancer	2.78e-06	5.07e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—COMT—breast cancer	2.78e-06	5.07e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—GSTP1—breast cancer	2.77e-06	5.05e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—CYP1A1—breast cancer	2.77e-06	5.05e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—CAV1—breast cancer	2.75e-06	5.01e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—ERCC2—breast cancer	2.75e-06	5e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ALDOA—breast cancer	2.74e-06	4.99e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—HMOX1—breast cancer	2.73e-06	4.98e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—ITPR1—breast cancer	2.73e-06	4.97e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—ABCB1—breast cancer	2.69e-06	4.89e-05	CbGpPWpGaD
Amprenavir—ABCC1—Disease—MAPK3—breast cancer	2.68e-06	4.89e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—NCOA3—breast cancer	2.66e-06	4.85e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—SLC2A2—breast cancer	2.64e-06	4.81e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—TYMS—breast cancer	2.64e-06	4.81e-05	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—PTEN—breast cancer	2.63e-06	4.79e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.63e-06	4.78e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—COMT—breast cancer	2.62e-06	4.78e-05	CbGpPWpGaD
Amprenavir—ABCC1—Disease—MYC—breast cancer	2.61e-06	4.76e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—GSTP1—breast cancer	2.61e-06	4.76e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PLA2G4A—breast cancer	2.61e-06	4.75e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—NCOR1—breast cancer	2.61e-06	4.75e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—GSTM1—breast cancer	2.61e-06	4.75e-05	CbGpPWpGaD
Amprenavir—ABCC1—Disease—TGFB1—breast cancer	2.6e-06	4.74e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—COMT—breast cancer	2.6e-06	4.74e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CPT1A—breast cancer	2.59e-06	4.72e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ABCG2—breast cancer	2.59e-06	4.72e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—MTR—breast cancer	2.59e-06	4.72e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—GSTP1—breast cancer	2.59e-06	4.71e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—MTHFR—breast cancer	2.58e-06	4.7e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—TYMS—breast cancer	2.58e-06	4.69e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—HMOX1—breast cancer	2.57e-06	4.69e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—ITPR1—breast cancer	2.57e-06	4.68e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—PIK3CG—breast cancer	2.56e-06	4.67e-05	CbGpPWpGaD
Amprenavir—ABCC1—Disease—EGFR—breast cancer	2.55e-06	4.65e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—HMOX1—breast cancer	2.55e-06	4.65e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—ITPR1—breast cancer	2.55e-06	4.64e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PLA2G4A—breast cancer	2.55e-06	4.64e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—NCOR1—breast cancer	2.55e-06	4.64e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—GSTM1—breast cancer	2.55e-06	4.64e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—HPGDS—breast cancer	2.54e-06	4.62e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—HBA1—breast cancer	2.52e-06	4.6e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—PIK3CG—breast cancer	2.51e-06	4.56e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—GPX1—breast cancer	2.5e-06	4.55e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—CYP1A1—breast cancer	2.47e-06	4.5e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—ABCB1—breast cancer	2.47e-06	4.5e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ACHE—breast cancer	2.46e-06	4.49e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—GSTT1—breast cancer	2.46e-06	4.49e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—ERCC2—breast cancer	2.45e-06	4.47e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—ABCB1—breast cancer	2.45e-06	4.46e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—GPX1—breast cancer	2.44e-06	4.44e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—TYMS—breast cancer	2.43e-06	4.42e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—CYP1A1—breast cancer	2.41e-06	4.4e-05	CbGpPWpGaD
Amprenavir—ABCC1—Disease—KRAS—breast cancer	2.41e-06	4.39e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—TYMS—breast cancer	2.41e-06	4.38e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—GSTM1—breast cancer	2.4e-06	4.37e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PLA2G4A—breast cancer	2.4e-06	4.37e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—NCOR1—breast cancer	2.4e-06	4.37e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—ERCC2—breast cancer	2.39e-06	4.36e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—CAV1—breast cancer	2.38e-06	4.34e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—NCOR1—breast cancer	2.38e-06	4.33e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PLA2G4A—breast cancer	2.38e-06	4.33e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—GSTM1—breast cancer	2.38e-06	4.33e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CYP17A1—breast cancer	2.33e-06	4.25e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ENO1—breast cancer	2.31e-06	4.2e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PTGS1—breast cancer	2.31e-06	4.2e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—MTHFR—breast cancer	2.31e-06	4.2e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—GPX1—breast cancer	2.3e-06	4.18e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—GPX1—breast cancer	2.28e-06	4.15e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.28e-06	4.15e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—CYP1A1—breast cancer	2.27e-06	4.14e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CYP2D6—breast cancer	2.26e-06	4.12e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—ERCC2—breast cancer	2.26e-06	4.11e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—CYP1A1—breast cancer	2.25e-06	4.11e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—PIK3CD—breast cancer	2.25e-06	4.1e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—MTHFR—breast cancer	2.25e-06	4.1e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—ERCC2—breast cancer	2.24e-06	4.07e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—ALB—breast cancer	2.22e-06	4.05e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—NCOA2—breast cancer	2.22e-06	4.05e-05	CbGpPWpGaD
Amprenavir—ABCC1—Disease—PIK3CA—breast cancer	2.22e-06	4.04e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—PIK3CD—breast cancer	2.2e-06	4.01e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—ALB—breast cancer	2.17e-06	3.96e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PIK3CG—breast cancer	2.17e-06	3.95e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—FASN—breast cancer	2.15e-06	3.92e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—BCHE—breast cancer	2.15e-06	3.91e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—NOS3—breast cancer	2.13e-06	3.88e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—CAV1—breast cancer	2.13e-06	3.87e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—MTHFR—breast cancer	2.12e-06	3.86e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—SLC5A5—breast cancer	2.12e-06	3.86e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—MTHFR—breast cancer	2.1e-06	3.83e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—NOS3—breast cancer	2.08e-06	3.79e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—CAV1—breast cancer	2.08e-06	3.78e-05	CbGpPWpGaD
Amprenavir—ABCC1—Disease—HRAS—breast cancer	2.05e-06	3.73e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—NQO1—breast cancer	2.05e-06	3.73e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—SLC2A1—breast cancer	2.05e-06	3.73e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	2.03e-06	3.7e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—PIK3CB—breast cancer	1.96e-06	3.58e-05	CbGpPWpGaD
Amprenavir—ABCC1—Disease—IL6—breast cancer	1.96e-06	3.57e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CYP1B1—breast cancer	1.96e-06	3.57e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—CAV1—breast cancer	1.96e-06	3.56e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—PTGS2—breast cancer	1.95e-06	3.54e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—CAV1—breast cancer	1.94e-06	3.53e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PIK3CG—breast cancer	1.94e-06	3.53e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—HSP90AA1—breast cancer	1.92e-06	3.5e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—PIK3CB—breast cancer	1.92e-06	3.5e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PIK3CD—breast cancer	1.91e-06	3.47e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—PTGS2—breast cancer	1.9e-06	3.46e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PIK3CG—breast cancer	1.89e-06	3.44e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—ALB—breast cancer	1.88e-06	3.43e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—NCOA1—breast cancer	1.87e-06	3.41e-05	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—PIK3CA—breast cancer	1.86e-06	3.38e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.85e-06	3.37e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CYP19A1—breast cancer	1.84e-06	3.36e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—STK11—breast cancer	1.84e-06	3.36e-05	CbGpPWpGaD
Amprenavir—ABCC1—Disease—AKT1—breast cancer	1.81e-06	3.3e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—NOS3—breast cancer	1.8e-06	3.28e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PIK3CG—breast cancer	1.78e-06	3.24e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PIK3CG—breast cancer	1.77e-06	3.22e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—COMT—breast cancer	1.72e-06	3.12e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—GSTP1—breast cancer	1.71e-06	3.11e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PIK3CD—breast cancer	1.7e-06	3.1e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—PTEN—breast cancer	1.7e-06	3.09e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—HMOX1—breast cancer	1.68e-06	3.07e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—ALB—breast cancer	1.68e-06	3.06e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ITPR1—breast cancer	1.68e-06	3.06e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PIK3CB—breast cancer	1.66e-06	3.03e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PIK3CD—breast cancer	1.66e-06	3.03e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—PTEN—breast cancer	1.66e-06	3.02e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PTGS2—breast cancer	1.65e-06	3e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—ALB—breast cancer	1.64e-06	2.99e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ABCB1—breast cancer	1.62e-06	2.94e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—NOS3—breast cancer	1.61e-06	2.93e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—TYMS—breast cancer	1.59e-06	2.89e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—NOS3—breast cancer	1.57e-06	2.86e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—GSTM1—breast cancer	1.57e-06	2.86e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—NCOR1—breast cancer	1.57e-06	2.86e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.57e-06	2.86e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PIK3CD—breast cancer	1.57e-06	2.85e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PIK3CD—breast cancer	1.55e-06	2.83e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—ALB—breast cancer	1.55e-06	2.82e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—ALB—breast cancer	1.53e-06	2.79e-05	CbGpPWpGaD
Amprenavir—ABCC1—Metabolism—AKT1—breast cancer	1.52e-06	2.76e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—GPX1—breast cancer	1.5e-06	2.74e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CYP1A1—breast cancer	1.49e-06	2.71e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PIK3CB—breast cancer	1.48e-06	2.7e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—NOS3—breast cancer	1.48e-06	2.69e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ERCC2—breast cancer	1.47e-06	2.69e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PTGS2—breast cancer	1.47e-06	2.68e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—NOS3—breast cancer	1.47e-06	2.67e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PIK3CB—breast cancer	1.45e-06	2.64e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PTEN—breast cancer	1.44e-06	2.62e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PTGS2—breast cancer	1.44e-06	2.61e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—MTHFR—breast cancer	1.39e-06	2.52e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PIK3CB—breast cancer	1.37e-06	2.49e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PIK3CB—breast cancer	1.35e-06	2.46e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PTGS2—breast cancer	1.35e-06	2.46e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PTGS2—breast cancer	1.34e-06	2.44e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PTEN—breast cancer	1.28e-06	2.34e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—CAV1—breast cancer	1.28e-06	2.33e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PTEN—breast cancer	1.25e-06	2.28e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—PIK3CA—breast cancer	1.2e-06	2.18e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PTEN—breast cancer	1.18e-06	2.15e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—PIK3CA—breast cancer	1.17e-06	2.13e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PTEN—breast cancer	1.17e-06	2.13e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PIK3CG—breast cancer	1.16e-06	2.12e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PIK3CD—breast cancer	1.02e-06	1.86e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—PIK3CA—breast cancer	1.01e-06	1.85e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—ALB—breast cancer	1.01e-06	1.84e-05	CbGpPWpGaD
Amprenavir—CYP2B6—Metabolism—AKT1—breast cancer	9.78e-07	1.78e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—NOS3—breast cancer	9.67e-07	1.76e-05	CbGpPWpGaD
Amprenavir—CYP3A5—Metabolism—AKT1—breast cancer	9.56e-07	1.74e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—PIK3CA—breast cancer	9.05e-07	1.65e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PIK3CB—breast cancer	8.93e-07	1.63e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PTGS2—breast cancer	8.84e-07	1.61e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—PIK3CA—breast cancer	8.83e-07	1.61e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—PIK3CA—breast cancer	8.32e-07	1.52e-05	CbGpPWpGaD
Amprenavir—CYP2C8—Metabolism—AKT1—breast cancer	8.28e-07	1.51e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—PIK3CA—breast cancer	8.25e-07	1.5e-05	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—PTEN—breast cancer	7.71e-07	1.4e-05	CbGpPWpGaD
Amprenavir—CYP2C19—Metabolism—AKT1—breast cancer	7.39e-07	1.35e-05	CbGpPWpGaD
Amprenavir—ABCB1—Metabolism—AKT1—breast cancer	7.21e-07	1.31e-05	CbGpPWpGaD
Amprenavir—CYP2D6—Metabolism—AKT1—breast cancer	6.8e-07	1.24e-05	CbGpPWpGaD
Amprenavir—CYP2C9—Metabolism—AKT1—breast cancer	6.74e-07	1.23e-05	CbGpPWpGaD
Amprenavir—CYP2C8—mammary gland—breast cancer	6.6e-07	0.0648	CbGeAlD
Amprenavir—ABCC1—nipple—breast cancer	6.41e-07	0.063	CbGeAlD
Amprenavir—CYP2C9—mammary gland—breast cancer	5.86e-07	0.0576	CbGeAlD
Amprenavir—CYP3A4—Metabolism—PIK3CA—breast cancer	5.44e-07	9.91e-06	CbGpPWpGaD
Amprenavir—CYP3A4—Metabolism—AKT1—breast cancer	4.44e-07	8.1e-06	CbGpPWpGaD
Amprenavir—ABCC1—endometrium—breast cancer	3.87e-07	0.038	CbGeAlD
Amprenavir—ABCC1—uterus—breast cancer	3.57e-07	0.035	CbGeAlD
Amprenavir—ABCC1—pituitary gland—breast cancer	3.5e-07	0.0344	CbGeAlD
Amprenavir—ABCC1—adipose tissue—breast cancer	3.49e-07	0.0343	CbGeAlD
Amprenavir—CYP2C8—endometrium—breast cancer	3.29e-07	0.0324	CbGeAlD
Amprenavir—CYP2B6—skin of body—breast cancer	3.13e-07	0.0308	CbGeAlD
Amprenavir—ABCC1—adrenal gland—breast cancer	3.13e-07	0.0307	CbGeAlD
Amprenavir—CYP2C8—pituitary gland—breast cancer	2.98e-07	0.0293	CbGeAlD
Amprenavir—ABCC1—female gonad—breast cancer	2.92e-07	0.0287	CbGeAlD
Amprenavir—CYP2C8—female reproductive system—breast cancer	2.73e-07	0.0268	CbGeAlD
Amprenavir—CYP3A5—adipose tissue—breast cancer	2.68e-07	0.0263	CbGeAlD
Amprenavir—CYP2C19—endocrine gland—breast cancer	2.65e-07	0.026	CbGeAlD
Amprenavir—CYP2B6—female reproductive system—breast cancer	2.45e-07	0.024	CbGeAlD
Amprenavir—CYP2C9—female reproductive system—breast cancer	2.42e-07	0.0238	CbGeAlD
Amprenavir—CYP2B6—adrenal gland—breast cancer	2.39e-07	0.0235	CbGeAlD
Amprenavir—CYP2C8—endocrine gland—breast cancer	2.31e-07	0.0227	CbGeAlD
Amprenavir—CYP3A5—female gonad—breast cancer	2.24e-07	0.022	CbGeAlD
Amprenavir—ABCB1—embryo—breast cancer	2.16e-07	0.0212	CbGeAlD
Amprenavir—CYP3A5—endocrine gland—breast cancer	2.08e-07	0.0205	CbGeAlD
Amprenavir—CYP2B6—endocrine gland—breast cancer	2.07e-07	0.0204	CbGeAlD
Amprenavir—CYP2C9—endocrine gland—breast cancer	2.05e-07	0.0202	CbGeAlD
Amprenavir—ABCC1—lymph node—breast cancer	1.87e-07	0.0184	CbGeAlD
Amprenavir—CYP3A4—female reproductive system—breast cancer	1.85e-07	0.0182	CbGeAlD
Amprenavir—CYP2D6—female reproductive system—breast cancer	1.82e-07	0.0179	CbGeAlD
Amprenavir—ABCB1—epithelium—breast cancer	1.76e-07	0.0173	CbGeAlD
Amprenavir—CYP2D6—female gonad—breast cancer	1.66e-07	0.0163	CbGeAlD
Amprenavir—ABCB1—endometrium—breast cancer	1.58e-07	0.0155	CbGeAlD
Amprenavir—CYP3A4—endocrine gland—breast cancer	1.56e-07	0.0154	CbGeAlD
Amprenavir—CYP2D6—endocrine gland—breast cancer	1.54e-07	0.0151	CbGeAlD
Amprenavir—ABCB1—uterus—breast cancer	1.46e-07	0.0143	CbGeAlD
Amprenavir—ABCB1—pituitary gland—breast cancer	1.43e-07	0.014	CbGeAlD
Amprenavir—ABCB1—adipose tissue—breast cancer	1.42e-07	0.014	CbGeAlD
Amprenavir—ABCB1—female reproductive system—breast cancer	1.31e-07	0.0129	CbGeAlD
Amprenavir—ABCB1—adrenal gland—breast cancer	1.28e-07	0.0125	CbGeAlD
Amprenavir—ABCB1—bone marrow—breast cancer	1.24e-07	0.0121	CbGeAlD
Amprenavir—ABCB1—female gonad—breast cancer	1.19e-07	0.0117	CbGeAlD
Amprenavir—ABCB1—endocrine gland—breast cancer	1.11e-07	0.0109	CbGeAlD
Amprenavir—ABCB1—lymph node—breast cancer	7.65e-08	0.00752	CbGeAlD
